Beaumont Financial Advisors LLC reduced its holdings in Azenta, Inc. (NASDAQ:AZTA – Free Report) by 22.2% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 24,531 shares of the company’s stock after selling 7,000 shares during the quarter. Beaumont Financial Advisors LLC’s holdings in Azenta were worth $1,598,000 at the end of the most recent quarter.
Other large investors have also bought and sold shares of the company. TFC Financial Management Inc. acquired a new position in Azenta in the third quarter valued at approximately $25,000. Headlands Technologies LLC acquired a new position in Azenta in the third quarter valued at approximately $33,000. State of Wyoming lifted its holdings in Azenta by 29.5% in the second quarter. State of Wyoming now owns 1,392 shares of the company’s stock valued at $65,000 after buying an additional 317 shares during the period. Neo Ivy Capital Management acquired a new stake in Azenta in the third quarter worth $73,000. Finally, Allworth Financial LP raised its holdings in Azenta by 273.1% in the fourth quarter. Allworth Financial LP now owns 1,634 shares of the company’s stock worth $106,000 after purchasing an additional 1,196 shares during the period. 99.08% of the stock is currently owned by institutional investors and hedge funds.
Azenta Stock Up 0.0 %
Shares of AZTA stock traded up $0.01 during trading hours on Friday, hitting $50.50. 193,103 shares of the company were exchanged, compared to its average volume of 424,806. The business has a 50 day moving average of $60.97 and a two-hundred day moving average of $58.91. Azenta, Inc. has a 52 week low of $36.01 and a 52 week high of $69.16.
Wall Street Analysts Forecast Growth
Several equities research analysts have weighed in on AZTA shares. Evercore ISI cut their target price on shares of Azenta from $64.00 to $60.00 and set an “in-line” rating on the stock in a report on Thursday, April 4th. Stephens reiterated an “equal weight” rating and issued a $70.00 target price on shares of Azenta in a report on Thursday, February 8th. Needham & Company LLC reiterated a “buy” rating and issued a $75.00 target price on shares of Azenta in a report on Monday, April 8th. Jefferies Financial Group started coverage on shares of Azenta in a report on Thursday, April 4th. They issued a “hold” rating and a $64.00 target price on the stock. Finally, B. Riley increased their target price on shares of Azenta from $61.00 to $79.00 and gave the stock a “buy” rating in a report on Thursday, February 1st. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $69.60.
View Our Latest Analysis on AZTA
Azenta Profile
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Further Reading
- Five stocks we like better than Azenta
- How to Invest in Insurance Companies: A Guide
- Comprehensive Analysis of PayPal Stock
- Technology Stocks Explained: Here’s What to Know About Tech
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What Investors Need to Know to Beat the Market
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.